86 related articles for article (PubMed ID: 12803887)
1. Lessons from an LPS-deficient Neisseria meningitidis mutant.
van der Ley P; Steeghs L
J Endotoxin Res; 2003; 9(2):124-8. PubMed ID: 12803887
[TBL] [Abstract][Full Text] [Related]
2. Outer membrane composition of a lipopolysaccharide-deficient Neisseria meningitidis mutant.
Steeghs L; de Cock H; Evers E; Zomer B; Tommassen J; van der Ley P
EMBO J; 2001 Dec; 20(24):6937-45. PubMed ID: 11742971
[TBL] [Abstract][Full Text] [Related]
3. Modification of lipid A biosynthesis in Neisseria meningitidis lpxL mutants: influence on lipopolysaccharide structure, toxicity, and adjuvant activity.
van der Ley P; Steeghs L; Hamstra HJ; ten Hove J; Zomer B; van Alphen L
Infect Immun; 2001 Oct; 69(10):5981-90. PubMed ID: 11553534
[TBL] [Abstract][Full Text] [Related]
4. Contributions of Neisseria meningitidis LPS and non-LPS to proinflammatory cytokine response.
Sprong T; Stikkelbroeck N; van der Ley P; Steeghs L; van Alphen L; Klein N; Netea MG; van der Meer JW; van Deuren M
J Leukoc Biol; 2001 Aug; 70(2):283-8. PubMed ID: 11493621
[TBL] [Abstract][Full Text] [Related]
5. Activation of human meningeal cells is modulated by lipopolysaccharide (LPS) and non-LPS components of Neisseria meningitidis and is independent of Toll-like receptor (TLR)4 and TLR2 signalling.
Humphries HE; Triantafilou M; Makepeace BL; Heckels JE; Triantafilou K; Christodoulides M
Cell Microbiol; 2005 Mar; 7(3):415-30. PubMed ID: 15679844
[TBL] [Abstract][Full Text] [Related]
6. Neisseria meningitidis lipid A mutant LPSs function as LPS antagonists in humans by inhibiting TLR 4-dependent cytokine production.
Sprong T; Ley Pv; Abdollahi-Roodsaz S; Joosten L; Meer Jv; Netea M; Deuren Mv
Innate Immun; 2011 Dec; 17(6):517-25. PubMed ID: 21088052
[TBL] [Abstract][Full Text] [Related]
7. Mannose binding lectin enhances IL-1beta and IL-10 induction by non-lipopolysaccharide (LPS) components of Neisseria meningitidis.
Sprong T; Jack DL; Klein NJ; Turner MW; van der Ley P; Steeghs L; Jacobs L; van der Meer JW; van Deuren M
Cytokine; 2004 Oct; 28(2):59-66. PubMed ID: 15381182
[TBL] [Abstract][Full Text] [Related]
8. Expression and involvement of Toll-like receptors (TLR)2, TLR4, and CD14 in monocyte TNF-alpha production induced by lipopolysaccharides from Neisseria meningitidis.
Mirlashari MR; Lyberg T
Med Sci Monit; 2003 Aug; 9(8):BR316-24. PubMed ID: 12942028
[TBL] [Abstract][Full Text] [Related]
9. Lipooligosaccharide-independent alteration of cellular homeostasis in Neisseria meningitidis-infected epithelial cells.
Bonnah RA; Hoelter J; Steeghs L; Enns CA; So M; Muckenthaler MU
Cell Microbiol; 2005 Jun; 7(6):869-85. PubMed ID: 15888088
[TBL] [Abstract][Full Text] [Related]
10. Teasing apart structural determinants of 'toxicity' and 'adjuvanticity': implications for meningococcal vaccine development.
Steeghs L; Tommassen J; Leusen JH; van de Winkel JG; van der Ley P
J Endotoxin Res; 2004; 10(2):113-9. PubMed ID: 15120002
[TBL] [Abstract][Full Text] [Related]
11. Activation of murine macrophages by Neisseria meningitidis and IFN-gamma in vitro: distinct roles of class A scavenger and Toll-like pattern recognition receptors in selective modulation of surface phenotype.
Mukhopadhyay S; Peiser L; Gordon S
J Leukoc Biol; 2004 Sep; 76(3):577-84. PubMed ID: 15218052
[TBL] [Abstract][Full Text] [Related]
12. Supplementation of whole-cell pertussis vaccines with lipopolysaccharide analogs: modification of vaccine-induced immune responses.
Geurtsen J; Fransen F; Vandebriel RJ; Gremmer ER; de la Fonteyne-Blankestijn LJ; Kuipers B; Tommassen J; van der Ley P
Vaccine; 2008 Feb; 26(7):899-906. PubMed ID: 18207288
[TBL] [Abstract][Full Text] [Related]
13. The Omp85 protein of Neisseria meningitidis is required for lipid export to the outer membrane.
Genevrois S; Steeghs L; Roholl P; Letesson JJ; van der Ley P
EMBO J; 2003 Apr; 22(8):1780-9. PubMed ID: 12682011
[TBL] [Abstract][Full Text] [Related]
14. Viability of a capsule- and lipopolysaccharide-deficient mutant of Neisseria meningitidis.
Bos MP; Tommassen J
Infect Immun; 2005 Sep; 73(9):6194-7. PubMed ID: 16113348
[TBL] [Abstract][Full Text] [Related]
15. A critical contribution of both CD28 and ICOS in the adjuvant activity of Neisseria meningitidis H44/76 LPS and lpxL1 LPS.
van Berkel ME; Schrijver EH; van Mourik A; Tesselaar K; van der Ley P; Steeghs L; Oosterwegel MA
Vaccine; 2007 Jun; 25(24):4681-8. PubMed ID: 17499399
[TBL] [Abstract][Full Text] [Related]
16. Expression of foreign LpxA acyltransferases in Neisseria meningitidis results in modified lipid A with reduced toxicity and retained adjuvant activity.
Steeghs L; Berns M; ten Hove J; de Jong A; Roholl P; van Alphen L; Tommassen J; van der Ley P
Cell Microbiol; 2002 Sep; 4(9):599-611. PubMed ID: 12390352
[TBL] [Abstract][Full Text] [Related]
17. Carbohydrate composition of meningococcal lipopolysaccharide modulates the interaction of Neisseria meningitidis with human dendritic cells.
Kurzai O; Schmitt C; Claus H; Vogel U; Frosch M; Kolb-Mäurer A
Cell Microbiol; 2005 Sep; 7(9):1319-34. PubMed ID: 16098219
[TBL] [Abstract][Full Text] [Related]
18. Complement activation induced by purified Neisseria meningitidis lipopolysaccharide (LPS), outer membrane vesicles, whole bacteria, and an LPS-free mutant.
Bjerre A; Brusletto B; Mollnes TE; Fritzsønn E; Rosenqvist E; Wedege E; Namork E; Kierulf P; Brandtzaeg P
J Infect Dis; 2002 Jan; 185(2):220-8. PubMed ID: 11807696
[TBL] [Abstract][Full Text] [Related]
19. Neisseria meningitidis type C capsular polysaccharide inhibits lipooligosaccharide-induced cell activation by binding to CD14.
Kocabas C; Katsenelson N; Kanswal S; Kennedy MN; Cui X; Blake MS; Segal DM; Akkoyunlu M
Cell Microbiol; 2007 May; 9(5):1297-310. PubMed ID: 17250593
[TBL] [Abstract][Full Text] [Related]
20. Meningitis caused by a lipopolysaccharide deficient Neisseria meningitidis.
Piet JR; Zariri A; Fransen F; Schipper K; van der Ley P; van de Beek D; van der Ende A
J Infect; 2014 Oct; 69(4):352-7. PubMed ID: 24932738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
